combined with hyperthermic intraperitoneal chemotherapy(CRS-HIPEC) prolongs the life of colon cancer PC patients.Here,we will review the clinical presentation,the mechanisms of disease progression,and current treatment options for colon cancer PC,with a focus on the benefits and limitations of CRSHIPEC...
this volume offers a "quick consultation with the experts" on contemporary treatment approaches in colon and rectal surgery. New chapters include coverage of anal carcinoma; anorectal pain syndromes; fecal impaction; rectocele; preoperative evaluation of the rectal cancer patient; pouchitis and complicatio...
About 30-40% of all colorectal cancer patients have rectal cancer. Rectal and colon cancer have much in common, whether in terms of etiology, risk factors, histology, but also in terms of palliative therapies in the metastatic setting without curative options. In particular, the survival times ...
Incidence rates for liver cancer began rising in the mid-1970s, and they are expected to go up through at least 2030. This report aims to give an overview of liver cancer, as well as explore current therapies, drugs in the pipeline and the future treatme
However, another clinical study on colon cancer has shown that KRAS mutation rates are higher in patients older than 50 years of age than in patients younger than 50 years of age [69]. Women over 64 years of age are more susceptible to mutations in the KRAS gene than men, and mutations...
It is normal for patients to want to start treatment as soon as possible after diagnosis; however, prostate cancer can grow very slowly, so patients have options. The array of therapeutic selections for patients with prostate cancer has expanded in recent years and choices depend on patient ...
tumorigenesis and immunogenicity, and proposed therapeutic strategies targeting epigenetic regulation. Methylation thus plays an essential role in tumorigenesis and disease progression, and a comprehensive understanding of methylation mechanisms can greatly facilitate advances in targeted cancer treatment options. ...
Genipin inhibits the invasion and migration of colon cancer cells by the suppression of HIF-1α accumulation and VEGF expression Food Chem. Toxicol., 116 (2018), pp. 70-76 Google Scholar [57] J. Jośko, B. Gwóźdź, H. Jedrzejowska-Szypułka, S. Hendryk ...
Drugs that target the endocannabinoid system are of interest as pharmacological options to combat cancer and to improve the life quality of cancer patients. From this perspective, cannabinoid compounds have been successfully tested as a systemic therapeu
Three major approaches of cancer therapy can be enunciated as delivery of biotherapeutics, tumor image analysis, and immunotherapy. Liposomes, artificial fat bubbles, are long known for their capacity to encapsulate a diverse range of bioactive molecules